| 000 | 01514 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516121358.0 | ||
| 264 | 0 | _c20130219 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1096-0333 | ||
| 024 | 7 |
_a10.1016/j.taap.2012.10.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, Jie | |
| 245 | 0 | 0 |
_aCYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cJan 2013 |
||
| 300 |
_a245-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtoxicity |
| 650 | 0 | 4 |
_aBile Acids and Salts _xmetabolism |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 |
_aCarnitine _xmetabolism |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2E1 _xmetabolism |
| 650 | 0 | 4 |
_aFatty Acids, Nonesterified _xmetabolism |
| 650 | 0 | 4 |
_aIsoniazid _xtoxicity |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolomics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aKrausz, Kristopher W | |
| 700 | 1 | _aLi, Feng | |
| 700 | 1 | _aMa, Xiaochao | |
| 700 | 1 | _aGonzalez, Frank J | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 266 _gno. 2 _gp. 245-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2012.10.024 _zAvailable from publisher's website |
| 999 |
_c22254977 _d22254977 |
||